Dayton Misfeldt Insider Trading $SNSS Viracta Therapeutics, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Dayton Misfeldt.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Dayton Misfeldt. Dayton Misfeldt is Director in SUNESIS PHARMACEUTICALS INC ($SNSS) and Interim CEO in SUNESIS PHARMACEUTICALS INC ($SNSS) and See Remarks in SUNESIS PHARMACEUTICALS INC ($SNSS).
Dayton Misfeldt in Viracta Therapeutics, Inc.
Trading Symbol: SNSSIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Dayton Misfeldt: See Remarks, Interim CEO, Director
Holdings: 1,598,260 shares
Current Value: $6,552,866
Latest Transaction: Jul 01 2020
$SNSS Market Capitalization: $85.18M
$SNSS Previous Close: $4.10
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Dayton Misfeldt in Viracta Therapeutics, Inc.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jul 01 2020 | SNSS | SUNESIS PHARMACEUT ... | Misfeldt Dayton | See Remarks | Option Exercise | A | 0.26 | 60,000 | 15,804 | 60,000 | |
Apr 02 2020 | SNSS | SUNESIS PHARMACEUT ... | Misfeldt Dayton | Interim CEO | Option Exercise | A | 0.41 | 480,000 | 199,152 | 480,000 | |
Jul 02 2019 | SNSS | SUNESIS PHARMACEUT ... | Misfeldt Dayton | Interim CEO | Option Exercise | A | 0.73 | 480,000 | 348,864 | 480,000 | |
Jul 02 2019 | SNSS | SUNESIS PHARMACEUT ... | Misfeldt Dayton | Interim CEO | Option Exercise | A | 0.73 | 60,000 | 43,608 | 60,000 | |
Jan 03 2019 | SNSS | SUNESIS PHARMACEUT ... | Misfeldt Dayton | Interim CEO | Option Exercise | A | 0.42 | 200,000 | 83,140 | 200,000 | |
Jul 03 2018 | SNSS | SUNESIS PHARMACEUT ... | Misfeldt Dayton | Interim CEO | Option Exercise | A | 2.12 | 25,000 | 53,000 | 25,000 | |
Jul 03 2018 | SNSS | SUNESIS PHARMACEUT ... | Misfeldt Dayton | Interim CEO | Option Exercise | A | 2.12 | 200,000 | 424,000 | 200,000 | |
Jan 02 2018 | SNSS | SUNESIS PHARMACEUT ... | Misfeldt Dayton | Interim CEO | Option Exercise | A | 3.69 | 200,000 | 738,000 | 200,000 | |
Oct 30 2017 | SNSS | SUNESIS PHARMACEUT ... | Misfeldt Dayton | Director | Option Exercise | P | 3.00 | 3,740 | 11,220 | 3,740 | |
Oct 30 2017 | SNSS | SUNESIS PHARMACEUT ... | Misfeldt Dayton | Director | Option Exercise | P | 3.00 | 196,260 | 588,780 | 196,260 | |
Oct 30 2017 | SNSS | SUNESIS PHARMACEUT ... | Misfeldt Dayton | Director | Buy | P | 2.00 | 7,480 | 14,960 | 30,456 | 23 K to 30.5 K (+32.56 %) |
Oct 30 2017 | SNSS | SUNESIS PHARMACEUT ... | Misfeldt Dayton | Director | Buy | P | 2.00 | 392,520 | 785,040 | 1,598,260 | 1.2 M to 1.6 M (+32.55 %) |
Jun 02 2017 | SNSS | SUNESIS PHARMACEUT ... | Misfeldt Dayton | Director | Option Exercise | A | 2.96 | 25,000 | 74,000 | 25,000 | |
Jul 05 2016 | SNSS | SUNESIS PHARMACEUT ... | Misfeldt Dayton | Director | Option Exercise | A | 0.55 | 50,000 | 27,385 | 50,000 | |
Dec 21 2015 | SNSS | SUNESIS PHARMACEUT ... | Misfeldt Dayton | Director | Buy | P | 0.84 | 32,725 | 27,489 | 137,859 | 105.1 K to 137.9 K (+31.13 %) |
Dec 21 2015 | SNSS | SUNESIS PHARMACEUT ... | Misfeldt Dayton | Director | Buy | P | 0.84 | 1,717,275 | 1,442,511 | 7,234,441 | 5.5 M to 7.2 M (+31.13 %) |
Dec 21 2015 | SNSS | SUNESIS PHARMACEUT ... | Misfeldt Dayton | Director | Option Exercise | X | 1.32 | 10,383 | 13,706 | 0 | |
Dec 21 2015 | SNSS | SUNESIS PHARMACEUT ... | Misfeldt Dayton | Director | Option Exercise | X | 1.32 | 20,766 | 27,411 | 0 | |
Dec 21 2015 | SNSS | SUNESIS PHARMACEUT ... | Misfeldt Dayton | Director | Option Exercise | X | 1.32 | 544,893 | 719,259 | 0 | |
Dec 21 2015 | SNSS | SUNESIS PHARMACEUT ... | Misfeldt Dayton | Director | Option Exercise | X | 1.32 | 1,089,788 | 1,438,520 | 0 | |
Dec 21 2015 | SNSS | SUNESIS PHARMACEUT ... | Misfeldt Dayton | Director | Sell | S | 3.64 | 3,962 | 14,422 | 105,134 | 109.1 K to 105.1 K (-3.63 %) |
Dec 21 2015 | SNSS | SUNESIS PHARMACEUT ... | Misfeldt Dayton | Director | Buy | X | 1.32 | 10,383 | 13,706 | 109,096 | 98.7 K to 109.1 K (+10.52 %) |
Dec 21 2015 | SNSS | SUNESIS PHARMACEUT ... | Misfeldt Dayton | Director | Sell | S | 3.46 | 7,925 | 27,421 | 98,713 | 106.6 K to 98.7 K (-7.43 %) |
Dec 21 2015 | SNSS | SUNESIS PHARMACEUT ... | Misfeldt Dayton | Director | Buy | X | 1.32 | 20,766 | 27,411 | 106,638 | 85.9 K to 106.6 K (+24.18 %) |
Dec 21 2015 | SNSS | SUNESIS PHARMACEUT ... | Misfeldt Dayton | Director | Sell | S | 3.46 | 207,938 | 719,465 | 5,517,166 | 5.7 M to 5.5 M (-3.63 %) |
Dec 21 2015 | SNSS | SUNESIS PHARMACEUT ... | Misfeldt Dayton | Director | Buy | X | 1.32 | 544,893 | 719,259 | 5,725,104 | 5.2 M to 5.7 M (+10.52 %) |
Dec 21 2015 | SNSS | SUNESIS PHARMACEUT ... | Misfeldt Dayton | Director | Sell | S | 3.46 | 415,877 | 1,438,934 | 5,180,211 | 5.6 M to 5.2 M (-7.43 %) |
Dec 21 2015 | SNSS | SUNESIS PHARMACEUT ... | Misfeldt Dayton | Director | Buy | X | 1.32 | 1,089,788 | 1,438,520 | 5,596,088 | 4.5 M to 5.6 M (+24.18 %) |
Jul 01 2015 | SNSS | SUNESIS PHARMACEUT ... | Misfeldt Dayton | Director | Option Exercise | A | 3.01 | 40,000 | 120,400 | 40,000 | |
Aug 29 2014 | SNSS | SUNESIS PHARMACEUT ... | Misfeldt Dayton | Director | Sell | S | 7.89 | 3,740 | 29,490 | 85,872 | 89.6 K to 85.9 K (-4.17 %) |
Aug 29 2014 | SNSS | SUNESIS PHARMACEUT ... | Misfeldt Dayton | Director | Sell | S | 7.89 | 196,260 | 1,547,530 | 4,506,300 | 4.7 M to 4.5 M (-4.17 %) |
Aug 29 2014 | SNSS | SUNESIS PHARMACEUT ... | Misfeldt Dayton | Director | Sell | S | 8.16 | 1,883 | 15,371 | 89,612 | 91.5 K to 89.6 K (-2.06 %) |
Aug 29 2014 | SNSS | SUNESIS PHARMACEUT ... | Misfeldt Dayton | Director | Sell | S | 8.16 | 98,817 | 806,643 | 4,702,560 | 4.8 M to 4.7 M (-2.06 %) |
Jul 01 2014 | SNSS | SUNESIS PHARMACEUT ... | Misfeldt Dayton | Director | Option Exercise | A | 6.52 | 20,000 | 130,400 | 20,000 | |
Aug 12 2014 | SNSS | SUNESIS PHARMACEUT ... | Misfeldt Dayton | Director | Sell | S | 6.77 | 694 | 4,700 | 91,495 | 92.2 K to 91.5 K (-0.75 %) |
Aug 12 2014 | SNSS | SUNESIS PHARMACEUT ... | Misfeldt Dayton | Director | Sell | S | 6.77 | 36,406 | 246,531 | 4,801,377 | 4.8 M to 4.8 M (-0.75 %) |
Aug 12 2014 | SNSS | SUNESIS PHARMACEUT ... | Misfeldt Dayton | Director | Sell | S | 6.90 | 591 | 4,079 | 92,189 | 92.8 K to 92.2 K (-0.64 %) |
Aug 12 2014 | SNSS | SUNESIS PHARMACEUT ... | Misfeldt Dayton | Director | Sell | S | 6.90 | 31,009 | 214,024 | 4,837,783 | 4.9 M to 4.8 M (-0.64 %) |
Aug 12 2014 | SNSS | SUNESIS PHARMACEUT ... | Misfeldt Dayton | Director | Sell | S | 6.62 | 12,622 | 83,559 | 92,780 | 105.4 K to 92.8 K (-11.98 %) |
Aug 12 2014 | SNSS | SUNESIS PHARMACEUT ... | Misfeldt Dayton | Director | Sell | S | 6.62 | 662,378 | 4,385,009 | 4,868,792 | 5.5 M to 4.9 M (-11.98 %) |
Jul 02 2013 | SNSS | SUNESIS PHARMACEUT ... | Misfeldt Dayton | Director | Option Exercise | A | 5.19 | 20,000 | 103,700 | 20,000 | |
Jul 02 2012 | SNSS | SUNESIS PHARMACEUT ... | Misfeldt Dayton | Director | Option Exercise | A | 2.87 | 25,000 | 71,750 | 25,000 | |
Jul 05 2011 | SNSS | SUNESIS PHARMACEUT ... | Misfeldt Dayton | Director | Option Exercise | A | 2.09 | 50,000 | 104,500 | 50,000 | |
Jul 01 2010 | SNSS | SUNESIS PHARMACEUT ... | Misfeldt Dayton | Director | Option Exercise | C | 0.00 | 18,690 | 0 | 0 | |
Jul 01 2010 | SNSS | SUNESIS PHARMACEUT ... | Misfeldt Dayton | Director | Option Exercise | C | 0.00 | 980,809 | 0 | 0 | |
Jul 01 2010 | SNSS | SUNESIS PHARMACEUT ... | Misfeldt Dayton | Director | Buy | C | 0.00 | 186,900 | 0 | 632,416 | 445.5 K to 632.4 K (+41.95 %) |
Jul 01 2010 | SNSS | SUNESIS PHARMACEUT ... | Misfeldt Dayton | Director | Buy | C | 0.00 | 9,808,090 | 0 | 33,187,024 | 23.4 M to 33.2 M (+41.95 %) |
Jul 01 2010 | SNSS | SUNESIS PHARMACEUT ... | Misfeldt Dayton | Director | Buy | P | 0.28 | 445,516 | 122,517 | 445,516 | 0 to 445.5 K |
Jul 01 2010 | SNSS | SUNESIS PHARMACEUT ... | Misfeldt Dayton | Director | Buy | P | 0.28 | 23,378,934 | 6,429,207 | 23,378,934 | 0 to 23.4 M |
Jun 08 2010 | SNSS | SUNESIS PHARMACEUT ... | Misfeldt Dayton | Director | Option Exercise | A | 0.82 | 10,000 | 8,150 | 10,000 | |
Nov 03 2009 | SNSS | SUNESIS PHARMACEUT ... | Misfeldt Dayton | Director | Option Exercise | P | 0.22 | 62,300 | 13,706 | 62,300 | |
Nov 03 2009 | SNSS | SUNESIS PHARMACEUT ... | Misfeldt Dayton | Director | Option Exercise | P | 0.22 | 3,269,360 | 719,259 | 3,269,360 | |
Nov 03 2009 | SNSS | SUNESIS PHARMACEUT ... | Misfeldt Dayton | Director | Option Exercise | P | 0.22 | 6,230 | 1,371 | 18,690 | |
Nov 03 2009 | SNSS | SUNESIS PHARMACEUT ... | Misfeldt Dayton | Director | Option Exercise | P | 0.22 | 326,936 | 71,926 | 980,809 | |
Apr 07 2009 | SNSS | SUNESIS PHARMACEUT ... | Misfeldt Dayton | Director | Option Exercise | A | 0.20 | 30,000 | 6,000 | 30,000 |
Page: 1